Clinical Study of CEA-Targeted CAR-T Therapy in Patients With Relapsed and Refractory CEA+ Cancer

Study Summary

This is a single arm study to evaluate the efficacy and safety of CEA-targeted CAR-T cells therapy for patients with relapsed/refractory CEA+ Cancer,and obtain the recommended dose and infusion plan.

Interventions

Study Locations

Facility	City	State	Country
Chongqing University Cancer Hospital	Chongqing	Chongqing Municipality	China
Henan Cancer Hospital	Henan		China

Official Trial Information

View on ClinicalTrials.gov